Literature DB >> 123216

A potent antimitogenic factor from group A streptococci.

A H Malakian, S Kaloustian.   

Abstract

A cytoplasmic component from group A streptococci produced complete suppression of human lymphocyte transformation induced by phytohaemagglutinin or the mixed lymphocyte reaction in vitro. It also suppressed antibody-forming cells in mice against sheep erythrocytes. The active substance was eluted as second and third fractions form Sephadex G-200 chromatography of the 100,000 g supernatant of sonically ruptured group A streptococci. The antimitogenic activity was not susceptible to trypsin, pronase, RNase or DNase digestion, but the activity was completely lost when it was sequentially digested, first with RNase and DNase and then with pronase. The active substance was not antigenic nor heat-labile at 56 degrees. It may be a protein component of a nucleoprotein.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 123216      PMCID: PMC1445765     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  6 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  The effect of a streptococcus pyogenes teichoic acid on the immune response of mice.

Authors:  G A Miller; R W Jackson
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

3.  Differential susceptibility of mouse lymphocytes to an immunosuppressant from group A streptococci.

Authors:  H R Gaumer; J H Schwab
Journal:  Cell Immunol       Date:  1972-08       Impact factor: 4.868

4.  "Nonspecific" stimulation of lymphocyte transformation by cellular fractions and acid extracts of group A streptococci.

Authors:  H Keiser; I Kushner; M H Kaplan
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

5.  Immunosuppressant from group A streptococci.

Authors:  A Malakian; J H Schwab
Journal:  Science       Date:  1968-02-23       Impact factor: 47.728

6.  Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts.

Authors:  M S Simberkoff; G J Thorbecke; L Thomas
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

  6 in total
  1 in total

1.  In vitro inhibition of human peripheral blood lymphocyte transformation by an extract of Pseudomonas putida.

Authors:  C V Hunt; W Khan; G Friedman; J C Houck
Journal:  Immunology       Date:  1977-08       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.